Our research is making a difference

Since 2010, the Irish Cancer Society has invested over €20 million into hundreds of innovative research projects. These projects have contributed enormously to our understanding of cancer, how it develops and how to treat different forms of cancer.

Our research has led to hundreds of discoveries. Each of these new findings have been published in international peer reviewed journals, making this knowledge available to researchers worldwide.

Why do research?

Data from the National Cancer Registry of Ireland, coupled with a growing population, means that this year around 40,000 people in Ireland are expected to be diagnosed with cancer.

Research into preventing, diagnosing and treating cancer is a must to help fight this disease.Research also helps identify the causes of cancer and is pointing the way to improved methods of diagnosis and treatment.

Irish cancer research success stories

Aspirin link discovered

International studies have shown that aspirin protects against some cancers. Irish Cancer Society-funded researchers have investigated this protective link in breast and prostate cancers.

One such study discovered that women who had been prescribed aspirin regularly before being diagnosed with breast cancer were less likely to have cancer that spread to the lymph-nodes than women who were not. While another project established that regular aspirin use prior to prostate cancer diagnosis was linked with a reduced risk of death. Read more

Increased survival in leukaemia

Irish Cancer Society funded research has played a part in the amazing journey that has led to targeted treatments and increased survival in Chronicmyeloid leukaemia (CML).

In the early 1990s, Professor Tom Cotter, whose research was funded by the Society, made a number of landmark discoveries. These discoveries not only advanced the field of leukaemia research, but also had major implications for the understanding and treatment of a number of human diseases. Read more.